A Phase Ii Trial Of Front-Line Double High Dose Chemotherapy (Hdct) With Dicep Then Beam And Autologous Stem Cell Transplantation (Asct) As Induction Therapy For Poor Prognosis Aggressive Non-Hodgkin'S Lymphoma (Nhl).
BLOOD（2002）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要